FDA approves Gilead's COVID-19 treatment for young children
The US agency has expanded its approval of Veklury to include use in pediatric patients 28 days and older who have tested positive for the COVID-19 virus.
Archives for April 26, 2022
Impel Pharmaceuticals upper-nasal delivery offers hope for migraine patients
The company’s Precision Olfactory Delivery technology, currently combined with its Trudhesa migraine treatment, reportedly facilitates high absorption rates.
Thread buys CureClick to bring crowdsourced enrollment platform to DCTs
The decentralized clinical trial specialist has acquired CureClick to add to its offerings a platform intended to expand awareness of study participation.